Safety, immunogenicity, and efficacy of the candidate tuberculosis vaccine MVA85A in healthy adults infected with HIV-1: a randomised, placebo-controlled, phase 2 trial
Open Access
- 25 February 2015
- journal article
- research article
- Published by Elsevier BV in The Lancet Respiratory Medicine
- Vol. 3 (3), 190-200
- https://doi.org/10.1016/s2213-2600(15)00037-5
Abstract
No abstract availableKeywords
Funding Information
- European & Developing Countries Clinical Trials Partnership (IP.07.32080.002)
- Aeras
- Bill & Melinda Gates Foundation
- Wellcome Trust (095780, 084323, 088316)
- Oxford-Emergent Tuberculosis Consortium
- Aeras
This publication has 27 references indexed in Scilit:
- Interferon release does not add discriminatory value to smear-negative HIV-tuberculosis algorithmsEuropean Respiratory Journal, 2011
- A Phase I study evaluating the safety and immunogenicity of MVA85A, a candidate TB vaccine, in HIV-infected adultsBMJ Open, 2011
- Modified vaccinia Ankara‐expressing Ag85A, a novel tuberculosis vaccine, is safe in adolescents and children, and induces polyfunctional CD4+ T cellsEuropean Journal of Immunology, 2009
- Viral Booster Vaccines Improve Mycobacterium bovis BCG-Induced Protection against Bovine TuberculosisInfection and Immunity, 2009
- MVA.85A Boosting of BCG and an Attenuated, phoP Deficient M. tuberculosis Vaccine Both Show Protective Efficacy Against Tuberculosis in Rhesus MacaquesPLOS ONE, 2009
- Safety and Immunogenicity of a New Tuberculosis Vaccine, MVA85A, in Mycobacterium tuberculosis–infected IndividualsAmerican Journal of Respiratory and Critical Care Medicine, 2009
- Safety and Immunogenicity of a New Tuberculosis Vaccine, MVA85A, in Healthy Adults in South AfricaThe Journal of Infectious Diseases, 2008
- Mucosal prime-boost vaccination for tuberculosis based on TLR triggering OprI lipoprotein from Pseudomonas aeruginosa fused to mycolyl-transferase Ag85AImmunology Letters, 2007
- Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectivenessThe Lancet, 2006
- Boosting with Poxviruses Enhances Mycobacterium bovis BCG Efficacy against Tuberculosis in Guinea PigsInfection and Immunity, 2005